Achyut Healthcare Intrinsic Value
Achyut Healthcare (ACHYUT) median intrinsic value is ₹7.50 from 3 valuation models (range ₹4–₹14), vs current price ₹5.78 — +29.8% upside (Trading Below Calculated Value), margin of safety 22.9%. For current market price and key ratios, visit ACHYUT screener.
ACHYUT Valuation Methods Summary — DCF, Graham Number & P/E
Achyut Healthcare intrinsic value across 3 models vs current price ₹5.78 — upside/downside and value range per method. Also explore Achyut Healthcare stock price data download to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹14.45 | ₹13.00 - ₹15.90 | +150.0% | Book Value/Share: ₹12.92, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹7.50 | ₹6.75 - ₹8.25 | +29.8% | Revenue/Share: ₹3.75, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹4.17 | ₹3.75 - ₹4.59 | -27.9% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
ACHYUT Intrinsic Value vs Market Price — All Valuation Models
Achyut Healthcare fair value range ₹4–₹14 vs current market price ₹5.78 across 3 valuation models. Browse ACHYUT balance sheet details for revenue, profit, balance sheet and cash flow data.
ACHYUT Intrinsic Value Analysis — Undervalued or Overvalued?
Achyut Healthcare median intrinsic value ₹7.50, current price ₹5.78 — Trading Below Calculated Value by 29.8%, margin of safety 22.9%.
What is the intrinsic value of ACHYUT?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Achyut Healthcare (ACHYUT) is ₹7.50 (median value). With the current market price of ₹5.78, this represents a +29.8% variance from our estimated fair value.
The valuation range spans from ₹4.17 to ₹14.45, indicating ₹4.17 - ₹14.45.
Is ACHYUT undervalued or overvalued?
Based on our multi-method analysis, Achyut Healthcare (ACHYUT) appears to be trading below calculated value by approximately 29.8%.
ACHYUT Financial Health — Key Ratios vs Industry Benchmarks
Achyut Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.27x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ACHYUT Cash Flow Quality — Operating & Free Cash Flow
Achyut Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-7 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |